A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
The DOI matches its Crossref record; 10 of the 11 references it cites were found in a registry or an index.
Abstract
The global endemic of cardiovascular diseases calls for improved risk assessment and treatment. Here, we describe an association between myocardial infarction (MI) and a common sequence variant on chromosome 9p21. This study included a total of 4587 cases and 12,767 controls. The identified variant, adjacent to the tumor suppressor genes CDKN2A and CDKN2B , was associated with the disease with high significance. Approximately 21% of individuals in the population are homozygous for this variant, and their estimated risk of suffering myocardial infarction is 1.64 times as great as that of noncarriers. The corresponding risk is 2.02 times as great for early-onset cases. The population attributable risk is 21% for MI in general and 31% for early-onset cases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and has also been robustly associated with CHD outcomes.(40-42)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Additionally, endometriosis and CHD may share common genetic susceptibilities.”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [41]
In the citing paper
“Since 2007, genomewide association analyses have identified more than 50 independent loci associated with the risk of coronary artery disease.7–15”
From Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease (2016) · cites this paper as [8]
In the citing paper
“Interestingly, atherosclerotic plaques from patients carrying a genetic variation at the 9p21 locus (which includes the CDKN2B gene), which has been associated with atherosclerosis in humans204,205, have reduced levels of calreticulin compared with atherosclerotic plaques from non-carriers203, further supporting a role for defective efferocytosis in cardiovascular disease206.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [204]
In the citing paper
“Examples include the region at 8q24 associated with prostate, breast, and colon cancer, 300 kb from the nearest gene (103, 104), and the region at 9q21 associated with myocardial infarction and T2D, 150 kb from the nearest genes encoding CDKN2A and CDKN2B (99–101, 105–107).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [107]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Genomic Control for Association Studies
Devlin, B., & Roeder, K. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00997.x · Cited by 3,162
The Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009
Vascular Cell Senescence: Contribution to Atherosclerosis
Minamino, T., & Komuro, I. (2007) · Circulation Research · doi:10.1161/01.res.0000256837.40544.4a · Cited by 542
Heritability of death from coronary heart disease: a 36‐year follow‐up of 20 966 Swedish twins
Zdravkovic, S., Wienke, A., Pedersen, N. L., Marenberg, M. E., Yashin, A. I., & De Faire, U. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01029.x · Cited by 511
Wang, Q., Rao, S., Shen, G.-Q., Li, L., Moliterno, D. J., Newby, L. K., Rogers, W. J., Cannata, R., Zirzow, E., Elston, R. C., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/381560 · Cited by 217
Samani, N. J. (2005) · The American Journal of Human Genetics · doi:10.1086/498653 · Cited by 126
Zintzaras, E., & Kitsios, G. D. (2006) · Journal of Human Genetics · doi:10.1007/s10038-006-0053-x · Cited by 24
Research works printed but not linked: 2
- T. Thom et al., Circulation113, e85 (2006).
- N. Mantel, W. Haenszel, J. Natl. Cancer Inst.22, 719 (1959).
Cited by
Items 701–800 of 1,001
Yari, M., Bitarafan, S., Broumand, M. A., Fazeli, Z., Rahimi, M., Ghaderian, S. M. H., Mirfakhraie, R., & Omrani, M. D. (2018) · PubMed Central · doi:10.22088/ijmcm.bums.7.1.1 · Cited by 23
Expression pattern in human macrophages dependent on 9p21.3 coronary artery disease risk locus
Zollbrecht, C., Grassl, M., Fenk, S., Höcherl, R., Hubauer, U., Reinhard, W., Esslinger, U. B., Ebert, S., Langmann, T., Stark, K. J., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.030 · Cited by 25
“risk factors, such as hypertension, hypercholesterolemia and smoking [3,5,6].”
BackgroundLin, H., Tsai, P., Liao, Y., Lin, T., Tai, C., Juo, S. H., & Lin, R. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318214ea49 · Cited by 25
Genetic origins, regulators, and biomarkers of cellular senescence
Torres, G., Salladay-Perez, I. A., Dhingra, A., & Covarrubias, A. J. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.08.007 · Cited by 25
The paraoxonase gene family and atherosclerosis
Seo, D., & Goldschmidt‐Clermont, P. J. (2009) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0029-3 · Cited by 23
Human genetics of diabetic vascular complications
Tang, Z., FANG, Z., & Zhou, L. (2013) · Journal of Genetics · doi:10.1007/s12041-013-0288-1 · Cited by 26
“Moreover, variations at chromosome 9p21 have been found to be significantly associated with CVD in the general population (Helgadottir et al. 2007; Mcpherson et al. 2007).”
BackgroundLong Non-Coding RNAs in Obesity-Induced Cancer
Yau, M. Y. C., Xu, L., Huang, C., & Wong, C. (2018) · Non-Coding RNA · doi:10.3390/ncrna4030019 · Cited by 25
The tumor suppression theory of aging
Wolf, A. M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111583 · Cited by 30
The past, present, and future of direct-to-consumer genetic tests
Helgason, A., & Stefánsson, K. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.1/ahelgason · Cited by 23
Genetics of coronary artery disease: focus on genome-wide association studies.
Baudhuin, L. M. (2009) · PubMed · Cited by 31
Svensson, P., Wahlstrand, B., Olsson, M. M., Froguel, P., Falchi, M., Bergman, R. N., McTernan, P. G., Hedner, T., Carlsson, L. M. S., & Jacobson, P. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.075 · Cited by 29
Capacidad predictiva de las funciones de riesgo cardiovascular: limitaciones y oportunidades
Baena-Díez, J. M., Ramos, R., & Marrugat, J. (2009) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(09)71500-6 · Cited by 33
Genetics of premature myocardial infarction
Roberts, R. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0030-2 · Cited by 25
Hu, W., Ding, H.-X., Ouyang, A., Zhang, X., Xu, Q., Han, Y., Zhang, X., & Jin, Y. (2019) · Bioscience Reports · doi:10.1042/bsr20182213 · Cited by 25
Prediction and management of CAD risk based on genetic stratification
Roberts, R., Campillo, A., & Schmitt, M. E. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.006 · Cited by 33
In Search for Genes Related to Atherosclerosis and Dyslipidemia Using Animal Models
Poznyak, A. V., Grechko, A. V., Wetzker, R., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062097 · Cited by 29
“3 locus, the expression of which is strongly associated with the incidence of coronary artery disease [63,64].”
BackgroundEngert, J. C., Lemire, M., Faith, J., Brisson, D., Fujiwara, T., Roslin, N. M., Brewer, C. G., Montpetit, A., Darmond-Zwaig, C., Renaud, Y., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201920 · Cited by 27
Genome-Wide Association Studies of Cancer
Jorgenson, E., & Witte, J. S. (2007) · Future Oncology · doi:10.2217/14796694.3.4.419 · Cited by 27
“Future perspective Genome-wide association studies have already successfully identified genetic variants underlying myocardial infarction [41–43], age-related macular degeneration [44,45], Type 1 diabetes [46], Type 2 diabetes [28–30,46,47], Crohn’s disease [48–50] and obesity [51,52], prostate cancer [21–23] and brea…”
BackgroundHakonarson, H. H., & Grant, S. F. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.06.001 · Cited by 33
Genetics of Atrial Fibrillation
Lubitz, S. A., Yi, B. A., & Ellinor, P. T. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.007 · Cited by 25
MTAP and CDKN2B genes are associated with myocardial infarction in Chinese Hans
Yang, X., Zhang, Q., Chen, M., Li, Q., Yang, Z.-S., Li, L., Cao, F., Chen, X., Liu, W., Li, J., et al. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.02.021 · Cited by 24
Additive Effects of Multiple Genetic Variants on the Risk of Coronary Artery Disease
Lluís-Ganella, C., Lucas, G., Subirana, I., Sentí, M., Jiménez-Conde, J., Marrugat, J., Tomás, M., & Elosúa, R. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70186-9 · Cited by 26
Wiki-Health: From Quantified Self to Self-Understanding
Li, Y., & Guo, Y. (2015) · Future Generation Computer Systems · doi:10.1016/j.future.2015.08.008 · Cited by 28
“Several associated variants [47-51] in human genomic information that are”
BackgroundVorderstrasse, A. A., Ginsburg, G. S., Kraus, W. E., Maldonado, M. C. J., & Wolever, R. Q. (2013) · Global Advances in Health and Medicine · doi:10.7453/gahmj.2013.035 · Cited by 25
Huang, Y., Hasegawa, H., Wang, S.-W., Ku, C., Lin, Y., Chiou, S., Hou, M., Wu, D., Tsai, E., Saito, S., et al. (2010) · BioMed Research International · doi:10.1155/2011/569034 · Cited by 28
Genetic Regulation of Platelet Receptor Expression and Function
Williams, M. S., Weiss, E. J., Sabatine, M. S., Simon, D. I., Bahou, W. F., Becker, L. C., Parise, L. V., Dauerman, H. L., French, P. A., Smyth, S. S., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.218131 · Cited by 24
on behalf of the FinnDiane Study Group, Fagerholm, E., Ahlqvist, E., Forsblom, C. M., Sandholm, N., Syreeni, A., Parkkonen, M., McKnight, A. J., Tarnow, L., Maxwell, A. P., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2587-0 · Cited by 23
How pleiotropic genetics of the musculoskeletal system can inform genomics and phenomics of aging
Karasik, D. (2010) · AGE · doi:10.1007/s11357-010-9159-3 · Cited by 27
“The underlying molecular mechanisms of aging remain a subject of debates (de Magalhaes et al. 2009): tissue deterioration might not be programmed, being just a function of increase in entropy ( Hayflick 2004 ).”
BackgroundMelton, P. E., Rutherford, S., Voruganti, V. S., Göring, H. H. H., Laston, S., Haack, K., Comuzzie, A. G., Dyer, T., Johnson, M. P., Kent, J. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq274 · Cited by 23
“Previous GWASs have demonstrated that several SNPs located on chromosome 9p21 are associated with risk for coronary heart disease (CHD) and/or myocardial infarction (MI) (15,16), indicating that this was an interesting chromosomal region for future research.”
BackgroundSystematic review regulatory principles of non-coding RNAs in cardiovascular diseases
Li, Y., Huo, C., Pan, T., Li, X., Jin, X., Lin, X., Chen, J., Zhang, J., Guo, Z., Xu, J., et al. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx095 · Cited by 25
LPA Gene Polymorphisms and Gene Expression Associated with Coronary Artery Disease
Song, Z., Cao, H., Wu, H., Zhou, L., & Qin, L. (2017) · BioMed Research International · doi:10.1155/2017/4138376 · Cited by 23
GWAS Reveal Targets in Vessel Wall Pathways to Treat Coronary Artery Disease
Turner, A. W., Wong, D., Dreisbach, C., & Miller, C. L. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00072 · Cited by 28
Cardioinformatics: the nexus of bioinformatics and precision cardiology
Khomtchouk, B. B., Tran, D.-T. T., Vand, K. A., Might, M., Gozani, O., & Assimes, T. L. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz119 · Cited by 24
“…associated with a 29% increased risk of CVD, these SNPs are in noncoding regions where the nearest genes ( CDKN2B , CDKN2A ) are > 100 Kb away, and the causality between these genes and susceptibility to atherosclerosis has not yet been ascertained [60–62].”
BackgroundLabos, C., Martinez, S. C., Wang, R. H. L., Lenzini, P. A., Pilote, L., Bogaty, P. M., Brophy, J. M., Engert, J. C., Cresci, S., & Thanassoulis, G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.029 · Cited by 28
Labos, C., Wang, R. H. L., Pilote, L., Bogaty, P. M., Brophy, J. M., Engert, J. C., & Thanassoulis, G. (2014) · Heart · doi:10.1136/heartjnl-2013-305416 · Cited by 22
A genetic risk score predicts cardiovascular events in patients with stable coronary artery disease
Christiansen, M. K., Nyegaard, M., Larsen, S. B., Grove, E. L., Würtz, M., Neergaard‐Petersen, S., Hvas, A., Jensen, H. K., & Kristensen, S. D. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.045 · Cited by 25
Genetics of diabetes complications
Alkayyali, S., & Lyssenko, V. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9543-x · Cited by 27
“The strongest and most extensively replicated loci of these associations are located on chromosome 9p21 (Helgadottir et al. 2007; Myocardial Infarction Genetics et al. 2009), harboring the ell-cycle genes CDKN2A and CDKN2B.”
Current Insights into the Joint Genetic Basis of Type 2 Diabetes and Coronary Heart Disease
Dauriz, M., & Meigs, J. B. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-013-0368-z · Cited by 25
Poduri, A., Khullar, M., Bahl, A., Sharma, Y. P., & Talwar, K. K. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0887 · Cited by 22
Çakmak, H. A., Bayoğlu, B., Durmaz, E., Can, G., Karadağ, B., Cengiz, M., Vural, V. A., & Yüksel, H. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5285 · Cited by 22
Prudente, S., Morini, E., Larmon, J., Andreozzi, F., Pietro, N. D., Nigro, A., Gervino, E. V., Mannino, G. C., Bacci, S., Hauser, T. H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.019 · Cited by 23
Susceptibility genes for coronary heart disease and myocardial infarction
Kibos, A., & Guerchicoff, A. (2011) · Acute Cardiac Care · doi:10.3109/17482941.2011.606477 · Cited by 22
Aging: Treating the Older Patient
Rosko, A. E., & Artz, A. S. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.11.007 · Cited by 22
Sotos‐Prieto, M., Baylín, A., Campos, H., Qi, L., & Mattei, J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004067 · Cited by 25
“LCRS estimated risk of MI, therefore higher LCRS values reflect a higher risk of MI. ‡A composite measure of total dietary intake of saturated fats, cholesterol, polyunsaturated fats, fiber, folate, and adipose tissue a-linolenic acid (ALA) and total trans fats.”
BackgroundResultInfluentialLandscape of the long non-coding RNA transcriptome in human heart
Jiang, C., Ding, N., Li, J., Jin, X., Li, X., Pan, T., Huo, C., Li, Y., Xu, J., & Li, X. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby052 · Cited by 24
Li, Y., Zhang, D., Zhang, Y., Xu, X., Bi, L., Zhang, M., Yu, B., & Zhang, Y. (2019) · Gene · doi:10.1016/j.gene.2019.02.085 · Cited by 26
Genetic Polymorphisms and the Cardiovascular Risk of Non-Steroidal Anti-Inflammatory Drugs
Germaine, C. G. S., Bogaty, P. M., Boyer, L., Hanley, J. A., Engert, J. C., & Brophy, J. M. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.352 · Cited by 25
Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes
Tousoulis, D., Briasoulis, Α., Παπαγεωργίου, Ν., Antoniades, C. A., & Stefanadis, C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.004 · Cited by 27
Human genetic variations: Beacons on the pathways to successful ageing
Cluett, C., & Melzer, D. R. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.06.009 · Cited by 24
Chromosome 9p21.3 is Associated with Early‐Onset Coronary Heart Disease in the Irish Population
Meng, W., Hughes, A. E., Patterson, C. C., Belton, C., Kee, F., & McKeown, P. (2008) · Disease Markers · doi:10.1155/2008/375617 · Cited by 22
Xu, J., Li, W., Bao, X., Ding, H., Chen, J., Zhang, W., Sun, K., Wang, J., Wang, X., Wang, H., et al. (2010) · Clinical Science · doi:10.1042/cs20100151 · Cited by 23
Franceschini, N., Hu, Y., Reiner, A. P., Buyske, S. G., Nalls, M. A., Yanek, L. R., Li, Y., Hindorff, L. A., Cole, S. A., Howard, B. V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113203 · Cited by 25
Arbiol‐Roca, A., Padró‐Miquel, A., Hueso, M., Navarro, E., Alía‐Ramos, P., González-Álvarez, M. T., Rama, I., Torrás, J., Grinyó, J., Cruzado, J. M., et al. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.12.029 · Cited by 23
Relationship between long noncoding RNAs and physiological risk factors of cardiovascular disease
Mazidi, M., Penson, P. E., Gluba-Brzózka, A., Rysz, J., & Banach, M. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.03.009 · Cited by 24
CDKN2B - AS may indirectly regulate coronary artery disease-associated genes via targeting miR - 92a
Cheng, M. L., An, S., & Li, J. (2017) · Gene · doi:10.1016/j.gene.2017.07.070 · Cited by 23
Zhang, X., Wen, F., Zuo, C., Li, M., Chen, H., & Wu, K. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7820 · Cited by 22
Beckie, T. M., Beckstead, J. W., & Groer, M. E. (2011) · Biological Research For Nursing · doi:10.1177/1099800411403469 · Cited by 23
Common genetic risk factors for coronary artery disease: new opportunities for prevention?
Hamrefors, V. (2015) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12289 · Cited by 26
“Interestingly, the SNPs on Chromosome 9 are not associated with any of the traditional CVD risk factors (Helgadottir et al., 2007; McPherson et al., 2007; Samani et al., 2007; Wellcome Trust Case Control Consortium, 2007), suggesting that the pathophysiological mechanisms are novel.”
BackgroundResultInfluentialGenetics and Personalized Medicine—a Role in Statin Therapy?
Patel, J., Abd, T., Blumenthal, R. S., Nasir, K., & Superko, H. R. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0384-y · Cited by 23
Genetic prediction of common diseases. Still no help for the clinical diabetologist!
Prudente, S., Dallapiccola, B., Pellegrini, F., Doria, A., & Trischitta, V. (2012) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2012.04.010 · Cited by 25
Liu, K.-Y., Muehlschlegel, J. D., Perry, T. E., Fox, A. A., Collard, C. D., Body, S. C., & Shernan, S. K. (2009) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.06.032 · Cited by 21
DNA methylation at the 9p21 glaucoma susceptibility locus is associated with normal-tension glaucoma
Burdon, K. P., Awadalla, M. S., Mitchell, P., Wang, J. J., White, A. J. R., Keane, M. C., Souzeau, E., Graham, S. L., Goldberg, I., Healey, P. R., et al. (2017) · Ophthalmic Genetics · doi:10.1080/13816810.2017.1413659 · Cited by 21
LncRNAs in genetic basis of glaucoma
Cissé, Y., Bai, L., & Meng, T. (2018) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2017-000131 · Cited by 21
Temel, Ş. G. (2018) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2018.90907 · Cited by 22
Molineros, J. E., Singh, B., Terao, C., Okada, Y., Kaplan, J., McDaniel, B., Akizuki, S., Sun, C., Webb, C. F., Looger, L. L., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01066 · Cited by 21
“Additional studies now document the direct effects of common variation in enhancer elements on enhancer states [70-73], gene expression [70, 74], and disease [75-79].”
BackgroundSouth Asian Heart Risk Assessment (SAHARA): Randomized Controlled Trial Design and Pilot Study
Samaan, Z., Schulze, K. M., Middleton, C. A., Irvine, J., Joseph, P., Mente, A., Shah, B. R., Paré, G., Desai, D., Anand, S. S., et al. (2013) · JMIR Research Protocols · doi:10.2196/resprot.2621 · Cited by 24
Role of genomics in cardiovascular medicine
Novelli, G., Predazzi, I. M., Mango, R., Romeo, F., & Mehta, J. L. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i12.428 · Cited by 25
Megakaryoblastic leukemia factor-1 gene in the susceptibility to coronary artery disease
Hinohara, K., Nakajima, T., Yasunami, M., Houda, S., Sasaoka, T., Yamamoto, K., Lee, B.-S., Shibata, H., Tanaka‐Takahashi, Y., Takahashi, M., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0698-6 · Cited by 20
Lp(a) Lipoprotein Redux — From Curious Molecule to Causal Risk Factor
Kathiresan, S. (2009) · New England Journal of Medicine · doi:10.1056/nejme0910792 · Cited by 22
AP-1 signaling modulates cardiac fibroblast stress responses
Whitehead, A. J., Atcha, H., Hocker, J. D., Ren, B., & Engler, A. J. (2023) · Journal of Cell Science · doi:10.1242/jcs.261152 · Cited by 23
Hadley, T. D., Agha, A. M., & Ballantyne, C. M. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00915-6 · Cited by 22
Zhang, X., Lucas, A., Veturi, Y., Drivas, T. G., Bone, W. P., Verma, A., Chung, W. K., Crosslin, D. R., Denny, J. C., Hebbring, S. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30678-w · Cited by 24
A myocardial infarction genetic risk score is associated with markers of carotid atherosclerosis
Hamrefors, V., Hedblad, B., Engström, G., Almgren, P., Sjögren, M., & Melander, O. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02472.x · Cited by 20
Harrison, S. C., Holmes, M. V., Agu, O., & Humphries, S. E. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.045 · Cited by 21
“This SNP was chosen as a candidate, following three separate GWAS reporting strong associations between SNPs in this region and coronary heart disease (CHD) in 2007 [21–23].”
BackgroundMethodVariantes genéticas, riesgo cardiovascular y estudios de asociación de genoma completo
Companioni, O., Rodríguez‐Esparragón, F., Fernández‐Aceytuno, A. M., & Pérez, J. C. R. (2011) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.01.010 · Cited by 22
Personalized Orthodontics, The Future of Genetics in Practice
Hartsfield, J. K. (2008) · Seminars in Orthodontics · doi:10.1053/j.sodo.2008.02.007 · Cited by 25
Interleukin 18 gene variation and risk of acute myocardial infarction
Koch, W., Wolferstetter, H., Schatke, A., Schömig, A., & Kastrati, A. (2011) · Cytokine · doi:10.1016/j.cyto.2011.09.006 · Cited by 20
Association between 9p21 Genomic Markers and Ischemic Stroke Risk: Evidence Based on 21 Studies
Ni, X., & Zhang, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090255 · Cited by 20
Sex Differential Genetic Effect of Chromosome 9p21 on Subclinical Atherosclerosis
Lin, H., Tsai, P., Lin, R., Khor, G., Sheu, S., & Juo, S. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015124 · Cited by 21
Hubacek, J. A., Vrablík, M., Dlouhá, D., Staněk, V., Gebauerova, M., Adámková, V., Češka, R., Dostálová, G., Linhart, A., Vítek, L., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.01.005 · Cited by 21
Aging increases p16INK4a expression in vascular smooth-muscle cells
Rodriguez-Menocal, L., Pham, S. M., Mateu, D., St-Pierre, M., Wei, Y., Pestana, I. A., Aı̈touche, A., & Vázquez-Padrón, R. I. (2009) · Bioscience Reports · doi:10.1042/bsr20080128 · Cited by 20
Impact of a Genetic Risk Score on Myocardial Infarction Risk Across Different Ethnic Populations
Joseph, P. G., Paré, G., Asma, S., Engert, J. C., Yusuf, S., & Anand, S. S. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.05.014 · Cited by 20
Brænne, I., Willenborg, C., Tragante, V., Kessler, T., Zeng, L., Reiz, B., Kleinecke, M., von Ameln, S., Willer, C. J., Laakso, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10928-4 · Cited by 22
Monogenic, Polygenic, and MicroRNA Markers for Ischemic Stroke
Wu, C., Sinha, B., Li, Y., Benowitz, L. I., Chen, Q., Zhang, Z., Patel, N. J., Aziz‐Sultan, M. A., Chiocca, E. A., & Wang, X. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1055-3 · Cited by 21
“Furthermore, a genetic variant in CDKN2A/CDKN2B located at chromosome 9p21 that has a widely reported association with myocardial infarction and coronary artery disease [66] was associated with LAA stroke across multiple cohorts [62, 67, 68].”
Genotype-Based Risk and Pharmacogenetic Sampling in Clinical Trials
Schork, N. J., & Topol, E. J. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400903572779 · Cited by 23
HapMap and Mapping Genes for Cardiovascular Disease
Musunuru, K., & Kathiresan, S. (2008) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.813675 · Cited by 23
Primer: strategies for identifying genes involved in renal disease
de Borst, M. H., Benigni, A., & Remuzzi, G. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0785 · Cited by 22
“and revealed susceptibility variants for myocardial infarction on human chromosome 9p21”
BackgroundJiang, F., Dong, Y., Wu, C., Yang, X., Zhao, L., Guo, J., Yang, L., Dong, J., Zheng, G.-Y., Cao, H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.017 · Cited by 21
Predictive genetic testing for coronary artery disease
Johansen, C. T., & Hegele, R. A. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/07388550903422075 · Cited by 18
Yiannakouris, N., Katsoulis, M., Dilis, V., Parnell, L. D., Trichopoulos, D., Ordovás, J. M., & Trichopoulou, A. D. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.02.033 · Cited by 21
Etiologic Puzzle of Coronary Artery Disease: How Important Is Genetic Component?
Butnariu, L. I., Florea, L., Bădescu, M. C., Țarcă, E., Costache, I. I., & Gorduza, E. V. (2022) · Life · doi:10.3390/life12060865 · Cited by 33
The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis
Xu, W., Xu, J., Sun, B., Chen, H., Wang, Y., Huang, F., Peng, X., & Jiang, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2128-4 · Cited by 19
Yiannakouris, N., Katsoulis, M., Trichopoulou, A. D., Ordovás, J. M., & Trichopoulos, D. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004387 · Cited by 24
García-Bermúdez, M., López‐Mejías, R., González‐Juanatey, C., Corrales, A., Castañeda, S., Miranda-Filloy, J. A., Gómez‐Vaquero, C., Fernández‐Gutiérrez, B., Balsa, A., Pascual‐Salcedo, D., et al. (2012) · DNA and Cell Biology · doi:10.1089/dna.2012.1672 · Cited by 27
Personalized Medicine: A Reality Within this Decade
Roberts, R. (2008) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-007-9001-1 · Cited by 21
Prospects of personalized medicine in cardiovascular diseases
Lenfant, C. J. M. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.018 · Cited by 23
Conde, L., Bevan, S., Sitzer, M., Klopp, N., Illig, T., Thiery, J., Seissler, J., Baumert, J., Raitakari, O. T., Kähönen, M. A. P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.031 · Cited by 19
“Recent genome-wide association studies (GWAS) have identified a number of single nucleotide polymorphisms (SNPs), which are associated with myocardial infarction and coronary artery disease (CAD) [1–6].”
BackgroundGenome-Wide Association Studies of Cardiovascular Disease in European and Non-European Populations
McPherson, R. (2014) · Current Genetic Medicine Reports · doi:10.1007/s40142-014-0033-y · Cited by 23
Coronary Artery Disease: Why We should Consider the Y Chromosome
Molina, E., Clarence, E. M., Ahmady, F., Chew, G. S., & Charchar, F. J. (2016) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.12.100 · Cited by 23
A Review of Lifetime Risk Factors for Mortality
Kuh, D. J., Hardy, R., Hotopf, M. H., Lawlor, D. A., Maughan, B., Westendorp, R., Cooper, R., Black, S., & Mishra, G. D. (2009) · British Actuarial Journal · doi:10.1017/s135732170000550x · Cited by 20
“…(GWAS) has successfully led to the discovery of novel genetic variants that have strong evidence for replication and that are outside of traditional candidate gene regions for several common diseases such as breast cancer and cardiovascular disease (Easton et al., 2007; Helgadottir et al., 2007).”
Background
Metadata
- Authors
- Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., Masson, G., Gudbjartsson, D. F., Magnusson, K. P., Andersen, K., Levey, A. I., Backman, V. M., Matthiasdottir, S., Jonsdottir, T., Palsson, S., Einarsdottir, H., Gunnarsdottir, S., Gylfason, A., Vaccarino, V., Hooper, W. C., Reilly, M. P., Granger, C. B., Austin, H., Rader, D. J., Shah, S. H., Quyyumi, A. A., Gulcher, J. R., Thorgeirsson, G., Thorsteinsdottir, U., Kong, A., & Stefansson, K.
- Affiliations
- deCODE genetics, Sturlugata 8, IS-101 Reykjavik, Iceland.
- deCODE Genetics (Iceland) (IS)
- Corresponding author
- Manolescu, Andrei
- Kong, Augustine
- ORCID
- Venue
- Science
- Published
- 2007-06-08
- Volume
- 316
- Issue
- 5830
- Pages
- 1491-1493
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2036198235
- Semantic Scholar
- c6c5bbe025441bb878530bbd85db55cb110ef15a
- Cited by
- 1,594
- References
- 11
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 25 · 2023: 30 · 2022: 28 · 2021: 56 · 2020: 39 · 2019: 60 · 2018: 80 · 2017: 71 · 2016: 71 · 2015: 87 · 2014: 97 · 2013: 92 · 2012: 130
- FWCI
- 98.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- myocardial infarction, chromosome 9p21, genetic susceptibility, CDKN2A, CDKN2B, tumor suppressor, single nucleotide polymorphisms, early-onset myocardial infarction, population attributable risk, cardiovascular risk
- MeSH terms
- Aged, Chromosome Mapping, Chromosomes, Human, Pair 9, Coronary Artery Disease, Female, Genotype, Haplotypes, Heterozygote, Homozygote, Humans, Male, Middle Aged, Myocardial Infarction, Risk Factors, Genetic Variation, Linkage Disequilibrium, Case-Control Studies, Age of Onset, Genes, p16, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.